CD4+/CD25+/FOXP3+ Treg cells work in gastric cancers through immunosuppression as oncogenes, while FOXP3 overexpression in patients with breast cancers indicates good prognosis as a tumor suppressor16,17. Here, FOXP3 is linked to breast cancer.